IMMUNIC, INC. — Director's Dealing 2024

Jan 19, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2024-01-17

Reporting Person: Nash Duane (Director, Executive Chairman)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-17	Stock Option	$1.21	A	300000	Acquired	2034-01-17	Common Stock (300000)	Direct

Footnotes

F1: The option vests in monthly increments over a period of one year from the grant date.